Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


2nd Novel Cancer Therapeutics Summit

25 Feb 2013 - 26 Feb 2013 - Las Vegas, NV, USA



Bookmark and Share


We welcome you to GTC's 2nd Novel Cancer Therapeutics Summit taking place on February 25-26, 2013 in Las Vegas, NV.  This summit brings together experts from academia and industry to discuss the emerging targets, therapeutics and strategies against cancer, as well as showcase ubiquitins' huge potential in the development of therapeutics.  Attendees will also receive updates on government policy, recent regulations, important investments and partnering strategies.


2nd Novel Cancer Therapeutics Summit
 consists of three concurrent conferences shown below:

 - 4th Cancer Targets & Therapeutics
 - 2nd Oncology Partnering & Deal-making
 - 3rd Ubiquitin Research & Drug Discovery  


Dedicated networking events have been incorporated to enhance the exchange of information between technology developers and end-users. The 2nd Novel Cancer Therapeutics Summit will provide a great opportunity for companies to expose products and services


Call for Papers!
To be considered for an oral presentation, please submit an abstract here by January 25, 2013. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.



Further information
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!